# Primary Aldosteronism In Hypertensive Patients in China

> **NCT03155139** · — · COMPLETED · sponsor: **Qifu Li** · enrollment: 3500 (actual)

## Conditions studied

- Hyperaldosteronism; Primary
- Hypertension Secondary

## Interventions

- **DIAGNOSTIC_TEST:** Aldosterone/renin ratio (ARR) testing
- **DIAGNOSTIC_TEST:** Confirmatory tests

## Key facts

- **NCT ID:** NCT03155139
- **Lead sponsor:** Qifu Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-03
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 3500 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03155139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03155139, "Primary Aldosteronism In Hypertensive Patients in China". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03155139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*